BioProcess Technology Consultants Inc. announced today the closing of its acquisition by BDO USA, LLP, one of the nation’s leading professional services organizations. The acquisition combines BPTC’s broad chemistry, manufacturing and controls consulting services with BDO’s existing capabilities in the life sciences and biopharmaceutical industries.
Founded in 1994, BPTC was a biologics CMC consulting firm, providing a full range of technical, regulatory, and strategic assistance related to the development and commercialization of biopharmaceutical products. BPTC assisted clients in developing manufacturing processes and strategies that enhanced the overall value of their products, while de-risking product development.
Howard L. Levine, Ph.D., BPTC founder, president and CEO will become managing director and national leader of the Bioprocess Technology Group within BDO’s Life Sciences practice and the majority of BPTC’s consultants will join the new BPTG. “Since our inception, we’ve worked with companies to advance and de-risk the biotherapeutic development process, address unmet medical needs and increase patient access to novel medicines,” said Levine. “We’re excited to join BDO’s Life Sciences practice to support clients across the entire product development and company lifecycles.”
“We are pleased to welcome BPTC’s knowledge and resources to enhance our focus in the life sciences industry and deepen our biopharmaceutical product development offerings,” said Eric Jia-Sobota, national leader of BDO’s Industry Specialty Services and Life Sciences practices. “Joining forces with BPTC strengthens our ability to assist life sciences companies in managing risk, maximizing profitability and fostering continued innovation to unlock new value and deliver improved outcomes.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Date: April 08, 2019
Source: AP News
